Filter
291
Text search:
GMP
Featured
26
86
Language
Document type
140
50
39
33
15
7
4
3
Countries
13
12
11
11
10
9
9
8
8
7
6
6
5
5
5
5
4
4
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
135
25
18
16
13
12
9
Toolboxes
44
36
27
11
8
7
6
5
4
2
2
2
2
1
1
1
1
Examination of the business behaviour of Boehringer Ingelheim, Bayer and Baxter in Uganda
The WHO Cholera Vaccine Position Paper (August 2017) highlights the importance of oral cholera vaccines (OCVs) as a key tool in outbreak response and prevention, alongside water, sanitation, and hygiene (WASH) measures. It recommends OCVs for high-risk populations, endemic areas, and humanitarian cr
...
First Revised Edition
March 2000
Document No. : FDA/SMC/CTD/GL-CCT/2013/01
Namibia guideline for submission of applications for registration of pharmaceuticals for human use in common technical document format.
This guideline is intended to provide recommendations to applicants wishing to submit applications for the registration of medicines. It represents the Medicines Control Council’s current thinking on the safety, quality and efficacy of medicines.
